Transkranielle Hirnstimulation nach Schlaganfall

Standard

Transkranielle Hirnstimulation nach Schlaganfall. / Hummel, F C; Gerloff, C.

in: NERVENARZT, Jahrgang 83, Nr. 8, 01.08.2012, S. 957-65.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

APA

Vancouver

Bibtex

@article{562191ddf0de4cd0bd7a8f0e33f2ea90,
title = "Transkranielle Hirnstimulation nach Schlaganfall",
abstract = "Stroke is the leading cause of disability in adults. In Germany an estimated 1.5 million stroke survivors have to cope with persisting sensorimotor or cognitive deficits and effective therapies are scarce. The idea of using non-invasive brain stimulation to treat neuropsychiatric diseases was already born more than 2,000 years ago (Scribonius largus, 43-48 AD). However, only the development of modern non-invasive brain stimulation methods, such as transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS) has made it possible to evaluate these ideas. The therapeutic value of these non-invasive brain stimulation methods is currently under study for several neuropsychiatric diseases, mostly in a proof-of-principle fashion. In this article the focus will be on non-invasive brain stimulation to enhance functional regeneration after stroke.",
keywords = "Humans, Stroke, Transcranial Magnetic Stimulation",
author = "Hummel, {F C} and C Gerloff",
year = "2012",
month = aug,
day = "1",
doi = "10.1007/s00115-012-3566-x",
language = "Deutsch",
volume = "83",
pages = "957--65",
journal = "NERVENARZT",
issn = "0028-2804",
publisher = "Springer",
number = "8",

}

RIS

TY - JOUR

T1 - Transkranielle Hirnstimulation nach Schlaganfall

AU - Hummel, F C

AU - Gerloff, C

PY - 2012/8/1

Y1 - 2012/8/1

N2 - Stroke is the leading cause of disability in adults. In Germany an estimated 1.5 million stroke survivors have to cope with persisting sensorimotor or cognitive deficits and effective therapies are scarce. The idea of using non-invasive brain stimulation to treat neuropsychiatric diseases was already born more than 2,000 years ago (Scribonius largus, 43-48 AD). However, only the development of modern non-invasive brain stimulation methods, such as transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS) has made it possible to evaluate these ideas. The therapeutic value of these non-invasive brain stimulation methods is currently under study for several neuropsychiatric diseases, mostly in a proof-of-principle fashion. In this article the focus will be on non-invasive brain stimulation to enhance functional regeneration after stroke.

AB - Stroke is the leading cause of disability in adults. In Germany an estimated 1.5 million stroke survivors have to cope with persisting sensorimotor or cognitive deficits and effective therapies are scarce. The idea of using non-invasive brain stimulation to treat neuropsychiatric diseases was already born more than 2,000 years ago (Scribonius largus, 43-48 AD). However, only the development of modern non-invasive brain stimulation methods, such as transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS) has made it possible to evaluate these ideas. The therapeutic value of these non-invasive brain stimulation methods is currently under study for several neuropsychiatric diseases, mostly in a proof-of-principle fashion. In this article the focus will be on non-invasive brain stimulation to enhance functional regeneration after stroke.

KW - Humans

KW - Stroke

KW - Transcranial Magnetic Stimulation

U2 - 10.1007/s00115-012-3566-x

DO - 10.1007/s00115-012-3566-x

M3 - SCORING: Zeitschriftenaufsatz

C2 - 22854873

VL - 83

SP - 957

EP - 965

JO - NERVENARZT

JF - NERVENARZT

SN - 0028-2804

IS - 8

ER -